z-logo
open-access-imgOpen Access
Predian in the complex treatment of patients with diabetes mellitus
Author(s) -
I. V. Grigorieva
Publication year - 1988
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99687
Subject(s) - diabetes mellitus , sulfonamide , medicine , coagulation , intensive care medicine , endocrinology , chemistry , stereochemistry
The aim of this work was to study the effectiveness of predian (sulfonamide developed at the Research Institute Servier, France) as a sugar-lowering agent, as well as its effect on the coagulation and antiplatelet systems of diabetic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here